S-ketamine and GABA-A-receptor interaction in humans: An exploratory study with I-123-iomazenil SPECT

Alexander Heinzel, Rainer Steinke, Thorsten Dirk Poeppel, Oliver Grosser, Bernhard Bogerts, Hans Otto, Georg Northoff

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Objective: We aimed to probe for regional cerebral effects of S-ketamine on in vivo GABA-A-receptor binding in healthy human subjects. Methods: We investigated I-123-iomazenil SPECT before, during and after administration of S-ketamine in a blinded placebo-controlled study design (n = 12 in both groups). Analyses of SPECT were performed with voxel-based statistical parametric mapping (SPM), and statistical comparisons were made between the groups. We also assessed biochemical and behavioural changes during S-ketamine infusion. Results: S-ketamine induced positive and negative symptoms measured by the Brief Psychiatric Rating scale (BPRS). It increased the cortisol and prolactin levels. Image analysis revealed significantly decreased I-123-iomazenil binding in bilateral dorsomedial prefrontal cortex during S-ketamine administration when compared to placebo. Conclusion: Our study delivers preliminary evidence for an in vivo interaction of S-ketamine with GABA-A-receptors in human dorsomedial prefrontal cortex.

Original languageEnglish
Pages (from-to)549-554
Number of pages6
JournalHuman Psychopharmacology
Volume23
Issue number7
DOIs
Publication statusPublished - 2008

Fingerprint

Ketamine
GABA-A Receptors
Single-Photon Emission-Computed Tomography
Prefrontal Cortex
Placebos
Brief Psychiatric Rating Scale
Prolactin
Hydrocortisone
iomazenil
Healthy Volunteers

Keywords

  • GABA-A
  • I-123-iomazenil
  • Medial prefrontal cortex
  • S-ketamine
  • SPECT

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Neurology
  • Pharmacology (medical)

Cite this

S-ketamine and GABA-A-receptor interaction in humans : An exploratory study with I-123-iomazenil SPECT. / Heinzel, Alexander; Steinke, Rainer; Poeppel, Thorsten Dirk; Grosser, Oliver; Bogerts, Bernhard; Otto, Hans; Northoff, Georg.

In: Human Psychopharmacology, Vol. 23, No. 7, 2008, p. 549-554.

Research output: Contribution to journalArticle

Heinzel, Alexander ; Steinke, Rainer ; Poeppel, Thorsten Dirk ; Grosser, Oliver ; Bogerts, Bernhard ; Otto, Hans ; Northoff, Georg. / S-ketamine and GABA-A-receptor interaction in humans : An exploratory study with I-123-iomazenil SPECT. In: Human Psychopharmacology. 2008 ; Vol. 23, No. 7. pp. 549-554.
@article{56d4bebda2934a5bb980fd9f8458c154,
title = "S-ketamine and GABA-A-receptor interaction in humans: An exploratory study with I-123-iomazenil SPECT",
abstract = "Objective: We aimed to probe for regional cerebral effects of S-ketamine on in vivo GABA-A-receptor binding in healthy human subjects. Methods: We investigated I-123-iomazenil SPECT before, during and after administration of S-ketamine in a blinded placebo-controlled study design (n = 12 in both groups). Analyses of SPECT were performed with voxel-based statistical parametric mapping (SPM), and statistical comparisons were made between the groups. We also assessed biochemical and behavioural changes during S-ketamine infusion. Results: S-ketamine induced positive and negative symptoms measured by the Brief Psychiatric Rating scale (BPRS). It increased the cortisol and prolactin levels. Image analysis revealed significantly decreased I-123-iomazenil binding in bilateral dorsomedial prefrontal cortex during S-ketamine administration when compared to placebo. Conclusion: Our study delivers preliminary evidence for an in vivo interaction of S-ketamine with GABA-A-receptors in human dorsomedial prefrontal cortex.",
keywords = "GABA-A, I-123-iomazenil, Medial prefrontal cortex, S-ketamine, SPECT",
author = "Alexander Heinzel and Rainer Steinke and Poeppel, {Thorsten Dirk} and Oliver Grosser and Bernhard Bogerts and Hans Otto and Georg Northoff",
year = "2008",
doi = "10.1002/hup.960",
language = "English",
volume = "23",
pages = "549--554",
journal = "Human Psychopharmacology",
issn = "0885-6222",
publisher = "John Wiley and Sons Ltd",
number = "7",

}

TY - JOUR

T1 - S-ketamine and GABA-A-receptor interaction in humans

T2 - An exploratory study with I-123-iomazenil SPECT

AU - Heinzel, Alexander

AU - Steinke, Rainer

AU - Poeppel, Thorsten Dirk

AU - Grosser, Oliver

AU - Bogerts, Bernhard

AU - Otto, Hans

AU - Northoff, Georg

PY - 2008

Y1 - 2008

N2 - Objective: We aimed to probe for regional cerebral effects of S-ketamine on in vivo GABA-A-receptor binding in healthy human subjects. Methods: We investigated I-123-iomazenil SPECT before, during and after administration of S-ketamine in a blinded placebo-controlled study design (n = 12 in both groups). Analyses of SPECT were performed with voxel-based statistical parametric mapping (SPM), and statistical comparisons were made between the groups. We also assessed biochemical and behavioural changes during S-ketamine infusion. Results: S-ketamine induced positive and negative symptoms measured by the Brief Psychiatric Rating scale (BPRS). It increased the cortisol and prolactin levels. Image analysis revealed significantly decreased I-123-iomazenil binding in bilateral dorsomedial prefrontal cortex during S-ketamine administration when compared to placebo. Conclusion: Our study delivers preliminary evidence for an in vivo interaction of S-ketamine with GABA-A-receptors in human dorsomedial prefrontal cortex.

AB - Objective: We aimed to probe for regional cerebral effects of S-ketamine on in vivo GABA-A-receptor binding in healthy human subjects. Methods: We investigated I-123-iomazenil SPECT before, during and after administration of S-ketamine in a blinded placebo-controlled study design (n = 12 in both groups). Analyses of SPECT were performed with voxel-based statistical parametric mapping (SPM), and statistical comparisons were made between the groups. We also assessed biochemical and behavioural changes during S-ketamine infusion. Results: S-ketamine induced positive and negative symptoms measured by the Brief Psychiatric Rating scale (BPRS). It increased the cortisol and prolactin levels. Image analysis revealed significantly decreased I-123-iomazenil binding in bilateral dorsomedial prefrontal cortex during S-ketamine administration when compared to placebo. Conclusion: Our study delivers preliminary evidence for an in vivo interaction of S-ketamine with GABA-A-receptors in human dorsomedial prefrontal cortex.

KW - GABA-A

KW - I-123-iomazenil

KW - Medial prefrontal cortex

KW - S-ketamine

KW - SPECT

UR - http://www.scopus.com/inward/record.url?scp=57149141413&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57149141413&partnerID=8YFLogxK

U2 - 10.1002/hup.960

DO - 10.1002/hup.960

M3 - Article

C2 - 18546441

AN - SCOPUS:57149141413

VL - 23

SP - 549

EP - 554

JO - Human Psychopharmacology

JF - Human Psychopharmacology

SN - 0885-6222

IS - 7

ER -